HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

GIGA-2050

recombinant hyperimmune polyclonal antibody against SARS-CoV-2

Also Known As:

GIGA 2050; GIGA2050

Networked: 1 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Amino Acids, Peptides, and Proteins: 1
- Proteins: 484843
  - Blood Proteins: 12459
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Neutralizing Antibodies: 9981
        GIGA-2050: 1
    - Immunoproteins: 43
      - Immunoglobulins: 30480
        Antibodies: 133716
        Neutralizing Antibodies: 9981
        GIGA-2050: 1
  - Globulins: 3062
    - Serum Globulins: 553
      - Immunoglobulins: 30480
        Antibodies: 133716
        Neutralizing Antibodies: 9981
        GIGA-2050: 1

Related Diseases

1.	COVID-19 07/19/2022 - "GIGA-2050 was purified and tested for good laboratory procedures (GLP) toxicology, pharmacokinetics, and in vivo efficacy against natural SARS-CoV-2 infection in mice. "